CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
The demand in Africa for COVID-19 vaccines has declined
Subscribe To Our Newsletter & Stay Updated
